Patent №
US 7,335,474
Granted
2008-02-26
Filed 2004
Owner
PERLEGEN SCIENCES, INC.
Lab
—
AI components
4
ml · nlp · kr · evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
10940410
Methods and systems for identifying biological marker-placebo effect correlations are provided. Clinical trial design and data analysis of clinical trial data is modified to accommodate marker-placebo effect correlations.
Machine learningNatural languageKnowledge representationEvolutionary computationG16B 25/10A61K 41/0004A61K 49/0004G16B 25/00G16B 50/10C12Q 1/6883G16B 20/00G16B 20/20+1 more
AI classification
Machine learning0.99
Evolutionary computation0.99
Knowledge representation0.96
Natural language0.75
Planning0.18
AI hardware0.05
Vision0.02
Speech0.00
Ownership
PERLEGEN SCIENCES, INC.
assignment · 161420855
Assignors
MARGUS, BRADLEY A, COX, DAVID R, HSU, JESSE
On an employer assignment, the assignors are typically the inventors.
From the same owner
METHODS FOR BREAST CANCER RISK ASSESSMENTUS 11,072,830 · 2021LIFE SCIENCES BUSINESS SYSTEMS AND METHODSUS 7,427,480 · 2008PHARMACEUTICAL AND DIAGNOSTIC BUSINESS SYSTEMS AND METHODSUS 7,135,286 · 2006METHODS FOR GENETIC ANALYSISUS 7,127,355 · 2006METHOD FOR IDENTIFYING MATCHED GROUPSUS 7,124,033 · 2006ARCHITECTURE FOR DEVELOPING AND REUSING ANALYTIC AND VISUALIZATION COMPONENTS AND METHODS OF USE THEREOFUS 7,058,657 · 2006LIFE SCIENCES BUSINESS SYSTEMS AND METHODSUS 6,955,883 · 2005